Rx Bio, INC.
Biomedical research and development
Based in TN
AI Overview
With $160K in lobbying spend across 11 quarterly filings, Rx Bio, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $90K |
| 2022 | $70K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Rx Bio, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
Promote RxBio's biomedical research and advancements among Congressional, Department of Defense and other federal stakeholders, with primary focus on the FY22 budget cycle and securing federal support
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.